PHX
PHARMX FPO [PHX]
Healthcare · ASX Small Cap
$0.1200 -4.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +4First seen: 2026-02-25
Score Breakdown
Technical53
Catalyst51
Sentiment50
Fundamental67
Momentum71
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Price at lower Bollinger Band (oversold)
- OBV divergence: accumulation detected
- Sharp 5-day decline (-17.2%)
- VPT accumulation divergence (bullish)
- Cash positive / operating cashflow positive
- Moderate P/S ratio (10.8x)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- CANSLIM S: Tight float (36%)
- Strong 12-1 momentum (+80%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Negative profit margins (-12%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Cleansing Notice
NONE Application for quotation of securities - PHX
NONE H1 FY26 Results Announcement
LOW H1 FY26 Investor Presentation
Recent ASX Announcements
| 2026-02-26 | Cleansing Notice |
| 2026-02-26 | Application for quotation of securities - PHX |
| 2026-02-24 | H1 FY26 Investor Presentation PRICE SENSITIVE |
| 2026-02-24 | H1 FY26 Results Announcement PRICE SENSITIVE |
| 2026-02-24 | Half Yearly Reports & Accounts PRICE SENSITIVE |
Key Metrics
$82.4M
Market Cap
1.1M
Avg Volume
1.8x
Vol Ratio
$0.07 — $0.20
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-5.9%
ROE
-12.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 36% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #55 of 119 · Sector avg: 51
View all Healthcare signals →